% This is the RIPE Database query service.
% The objects are in RPSL format.
%
% The RIPE Database is subject to Terms and Conditions.
% See https://apps.db.ripe.net/docs/HTML-Terms-And-Conditions
% Information related to '193.108.176.0 - 193.108.176.255'
% Abuse contact for '193.108.176.0 - 193.108.176.255' is '[email protected]'
inetnum: 193.108.176.0 - 193.108.176.255
netname: DIMDI-NET
org: ORG-DDIF1-RIPE
country: DE
admin-c: OZ444-RIPE
tech-c: OZ444-RIPE
status: ASSIGNED PI
mnt-by: RIPE-NCC-END-MNT
mnt-by: PLUSLINE-MNT
created: 1970-01-01T00:00:00Z
last-modified: 2022-11-10T14:47:16Z
source: RIPE
sponsoring-org: ORG-PSG2-RIPE
organisation: ORG-DDIF1-RIPE
org-name: Bundesinstitut fuer Arzneimittel und Medizinprodukte (BfArM)
country: DE
org-type: OTHER
address: Kurt-Georg-Kiesinger-Allee 3, D-53175 Bonn, GERMANY
e-mail: [email protected]
mnt-ref: PLUSLINE-MNT
mnt-by: PLUSLINE-MNT
abuse-c: DAH23-RIPE
created: 2013-05-21T12:03:38Z
last-modified: 2022-12-01T16:22:02Z
source: RIPE
person: Oliver Zeidler
address: Bundesinstitut fuer Arzneimittel und Medizinprodukte (BfArM)
address: Kurt-Georg-Kiesinger-Allee 3, D-53175 Bonn, GERMANY
phone: +49 (0) 228 99 307-4868
e-mail: [email protected]
nic-hdl: OZ444-RIPE
mnt-by: PLUSLINE-MNT
created: 2014-02-27T10:51:36Z
last-modified: 2022-10-31T09:18:30Z
source: RIPE